Literature DB >> 7105631

The effect of bromocriptine on circulating vasopressin.

B G Robinson, P Clifton-Bligh, S Posen, B J Morris.   

Abstract

1. The oral administration of 2.5 mg of the dopamine (3,4-dihydroxyphenethylamine) agonist bromoergocriptine enhanced the osmotically stimulated rise in plasma [arginine]vasopressin ([Arg]VP) concentrations in five normal human subjects. 2. This finding lends support to the suggestion that the osmotically induced release of [Arg]VP is under dopaminergic control in man.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105631     DOI: 10.1042/cs0630367

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  Hyponatraemia and dopaminergic agents.

Authors:  A J Larner
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401

2.  Bromocriptine-associated hyponatraemia in cirrhosis.

Authors:  A W Marshall; A W Jakobovits; M Y Morgan
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

Review 3.  Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management.

Authors:  T Y Chan
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.